Cargando…
A Case Report of a Poor Metabolizer of CYP2D6 Presented with Unusual Responses to Nortriptyline Medication
We present a case with decreased metabolic activity of CYP2D6, a cytochrome P450 enzyme catalyzing the metabolism of nortriptyline (NT). Conventional dosage regimen led to toxic plasma concentration of NT and adverse effects such as dry mouth, constipation, and dizziness in this case with genotype C...
Autores principales: | Lee, Soo-Youn, Ki, Chang-Seok, Hong, Kyung Sue, Kim, Jong Won |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2816343/ https://www.ncbi.nlm.nih.gov/pubmed/15483356 http://dx.doi.org/10.3346/jkms.2004.19.5.750 |
Ejemplares similares
-
Neuroprotective Effect of Nortriptyline in Overt Hepatic Encephalopathy Through Attenuation of Mitochondrial Dysfunction
por: Jeong, Ji Heun, et al.
Publicado: (2018) -
Amitriptyline/nortriptyline: Lack of efficacy: case report
Publicado: (2022) -
Cyclodextrin’s Effect on Permeability and Partition of Nortriptyline Hydrochloride
por: Volkova, Tatyana, et al.
Publicado: (2023) -
A Model Based Cost-Effectiveness Analysis of Routine Genotyping for CYP2D6 among Older, Depressed Inpatients Starting Nortriptyline Pharmacotherapy
por: Berm, Elizabeth J. J., et al.
Publicado: (2016) -
Early management of parotid gland injury with oral nortriptyline and closed drain
por: Chung, Chan Min, et al.
Publicado: (2020)